Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2011
02/22/2011US7892796 Solid support assay systems and methods utilizing non-standard bases
02/22/2011US7892794 Using apparatus which generates alternating electric pulses to isolate preferential bioparticles from gas; utilizing cyclic replication to amplify recovered biopolymers
02/22/2011US7892791 Fluorescent protein and chromoprotein
02/22/2011US7892785 In vito translation o proteins; obtain nucleotide sequences, incubate with reaction mixtures, translate, recover proteins
02/22/2011US7892782 Screening process for antibacterial agents
02/22/2011US7892775 Fluorescence assay for kinase activity
02/22/2011US7892774 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
02/22/2011US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system
02/22/2011US7892770 Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
02/22/2011US7892769 Processing of EphA4 polypeptide by γ-secretase activity
02/22/2011US7892768 Using presence of collagen IX alpha-1chain polypeptide fragments as diagnostic indicator of arthritic, bone, cardiovascular and/or inflammatory disorders
02/22/2011US7892767 Phosphospecific chemokine receptor antibodies
02/22/2011US7892766 Continuous flow chamber device for separation, concentration, and/or purification of cells
02/22/2011US7892765 Methods of screening modulators of hetero-oligomeric sweet taste receptors
02/22/2011US7892764 Inhibiting acid sensing ion channel 1a (ASIC1a); epilepsy; using PcTX1 or peptide derivative and/or amiloride or derivative
02/22/2011US7892763 Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
02/22/2011US7892762 Method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel disease
02/22/2011US7892761 Protein markers for diagnosing stomach cancer and the diagnostic kit using them
02/22/2011US7892760 Lung cancer markers, and uses thereof
02/22/2011US7892759 Enhanced sensitivity of a cantilever sensor via specific bindings
02/22/2011US7892758 Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis
02/22/2011US7892757 Immunochemical determination method and determination reagent for cytochrome c
02/22/2011US7892756 Human salty taste receptor and methods of modulating salty taste perception
02/22/2011US7892755 Of nitroquinoxaline-2,3-diones or ellagic acid as binding ligands for G protein coupled receptor 35; antidiabetic agents; anticarcinogenic agents for gastrointestinal cancer; obesity, immunotherapy
02/22/2011US7892754 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
02/22/2011US7892753 Diagnostic and therapeutic applications of soluble LHCGR protein
02/22/2011US7892752 Glycosylation markers for cancer diagnosing and monitoring
02/22/2011US7892751 Using antiphospholipid autoantibody expression profile as evaluative tool in screening for alzheimer's disease
02/22/2011US7892750 Cathepsin E as a marker of colon cancer
02/22/2011US7892749 Methods for differentiating and monitoring parathyroid and bone status related diseases
02/22/2011US7892748 Reagent for detecting an analyte
02/22/2011US7892730 Nucleotide sequences coding polypeptide for use in the treatment of and detection of cancer
02/22/2011US7892729 Universal and differential serologic assay for swine influenza virus
02/22/2011US7892727 Chemokine-binding protein and methods of use
02/22/2011US7892561 Neutralizing GDF8 epitope-based growth enhancing vaccine
02/22/2011US7892559 Major histocompatibility complex class I restricted epitope peptide for use in diagnosis, prevention and treament of cell proliferative disorders; antitumor agents
02/22/2011US7892557 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof
02/22/2011US7892551 Antibody kit for enumeration of CD4+ lymphocytes
02/22/2011US7892548 121P1F1: a tissue specific protein highly expressed in various cancers
02/22/2011US7892544 Humanized anti-beta-amyloid antibody
02/22/2011US7892539 Modulation of an innate immune response by altering TRIAL-R signaling
02/22/2011US7892493 Fluid sample transport device with reduced dead volume for processing, controlling and/or detecting a fluid sample
02/22/2011US7892415 Mesoporous platinum electrode and method for detecting biochemical substrate using the mesoporous platinum electrode
02/22/2011US7891233 Blast movement monitor
02/22/2011CA2525240C Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers
02/22/2011CA2456829C Reference control for high-sensitivity c-reactive protein testing
02/22/2011CA2455932C Assay electrodes having immobilized lipid/protein layers, methods of making the same and methods of using the same for luminescence test measurements
02/22/2011CA2441566C Blood cell production via activation of the hemoglobin scavenger receptor
02/22/2011CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/22/2011CA2433281C Rapid and quantitative proteome analysis and related methods
02/22/2011CA2422765C Assay method and kit therefor
02/22/2011CA2410193C Neuronal serine-threonine protein kinase
02/22/2011CA2409208C Method for examining wt1-related disease
02/22/2011CA2404429C Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen
02/22/2011CA2253875C Early detection of lysosomal storage disorders
02/17/2011WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use
02/17/2011WO2011020069A1 Bacterial strain identification method and system
02/17/2011WO2011020011A2 Droplet actuator and droplet-based techniques
02/17/2011WO2011019980A1 Novel role of alpha-galactosidase activity as a biomarker in kidney disease
02/17/2011WO2011019932A2 Compositions and methods for the therapy and diagnosis of influenza
02/17/2011WO2011019929A1 Methods of diagnosing and treating autism
02/17/2011WO2011019864A2 Methods for mobile zinc measurement
02/17/2011WO2011019822A2 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
02/17/2011WO2011019807A2 Measurement of mitochondrial membrane potential to assess organ dysfunction
02/17/2011WO2011019787A1 Apparatus to determine coefficient of friction
02/17/2011WO2011019558A1 Methods to measure dissociation rates for ligands that form reversible covalent bonds
02/17/2011WO2011019556A1 CO-CRYSTALLIZATION OF ERR-A α WITH A LIGAND THAT FORMS A REVERSIBLE CONVALENT BOND
02/17/2011WO2011019516A2 Microfluidic diagnostic device
02/17/2011WO2011019363A1 Detection of hepatic insulin resistance
02/17/2011WO2011019286A1 Method of detecting pneumocandin compounds
02/17/2011WO2011019082A1 Method for measuring autophagy
02/17/2011WO2011019074A1 Nucleic acid that controls fibrosis of cells or organs
02/17/2011WO2011019072A1 Biomarker for depression, method for measuring a biomarker for depression, computer program, and recording medium
02/17/2011WO2011019068A1 Urinary function measuring device for animal and urinary function measuring method for animal
02/17/2011WO2011019030A1 Coating apparatus and liquid substance coating method
02/17/2011WO2011018710A2 Biological components within the cerebrospinal fluid
02/17/2011WO2011018669A2 A condenser for breath condensate
02/17/2011WO2011018667A1 Endonuclease g as target for hypertension and hypertrophy associated diseases
02/17/2011WO2011018665A1 Complexing system
02/17/2011WO2011018618A2 Assay device
02/17/2011WO2011018613A1 Functionalisation of solid substrates
02/17/2011WO2011018611A1 Reversible covalent linkage of functional molecules
02/17/2011WO2011018586A2 Method for predetermining the binding of a given compound to a membrane receptor
02/17/2011WO2011018451A1 Nanoparticle screening methods employing insects with blood brain barrier
02/17/2011WO2011018450A1 Insect-based model for pharmaco-kinetic studies
02/17/2011WO2011018449A1 Methods employing insect models for determining intestinal absorption of chemical compounds
02/17/2011WO2011018446A1 Insect-based ex vivo model for testing blood-brain barrier penetration and method for exposing insect brain to chemical compounds
02/17/2011WO2011018421A1 Novel screening strategies for the identification of binders
02/17/2011WO2011018288A1 Means and methods for diagnosingthyroid disorders
02/17/2011WO2011018241A1 Methods for the identification and characterization of hdac interacting compounds
02/17/2011WO2011018184A1 Fluorescence-based imaging and analysis of cells and cellular components using lipophilic dyes with improved specificity, spectral properties and photostability
02/17/2011WO2011018172A1 Test element for analyzing a body fluid
02/17/2011WO2011018149A1 Test element for analyzing a body fluid
02/17/2011WO2011018107A1 Method and device for measuring physical characteristics of biological samples
02/17/2011WO2011018090A1 Predictive marker for hydroxyurea resistance
02/17/2011WO2011018067A1 Method for separating particles and/or cells having 2 and more surface specificities
02/17/2011WO2011017959A1 Fruit maturity determination method and system
02/17/2011WO2011017916A1 Solvatochromic functional monomer and use thereof for chemosensing by solvatochromic molecular imprinting
02/17/2011WO2011017911A1 Detection device and method of using the same
02/17/2011WO2011017792A1 Extractive analytical method for tannins determination on raw materials and plant products